Elevated levels of FT4 are associated with an augmented risk of thrombosis, indicative of a heightened likelihood of thromboembolic diseases (44–46), and thyroid hormones regulate coagulation processes through various mechanisms. This evidence concerns the gene TG and Thromboembolism.